Fed. Circ. Affirms Nix Of Novartis Dementia Patch Patents
The Federal Circuit on Tuesday upheld a Patent Trial and Appeal Board decision that the challenged claims of two Novartis patents covering the dementia patch Exelon were invalid as obvious, affirming...To view the full article, register now.
Already a subscriber? Click here to view full article